Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Oct 27, 2021; 13(10): 1245-1257
Published online Oct 27, 2021. doi: 10.4240/wjgs.v13.i10.1245
Figure 2
Figure 2 The survival curves of the postoperative complete remission (-), tyrosine kinase inhibitors (TKIs) (+) and postoperative complete remission (-),tyrosine kinase inhibitors (-) groups after reduction hepatectomy. The cases in which postoperative complete remission (POCR) was not achieved despite tyrosine kinase inhibitors (TKIs) treatment being administered in the postoperative period were included in the POCR (-) TKI (+) group (green line). The cases in which POCR was not achieved and TKIs were not administered in the postoperative period were included in the POCR (-) TKI (-) group (gray line).